Table 1.
Vaccines currently approved by at least one country
| Vaccine | Type | Phase trials | Approval | Results published |
|---|---|---|---|---|
| Pfizer-BioNtech |
mRNA |
Completed Phase 3 |
Emergency use validation from WHO |
Yes |
| Approved in 85 countries | ||||
| Moderna |
mRNA |
Completed Phase 3 |
Emergency use validation from WHO |
Yes |
| Approved in 46 countries | ||||
| Oxford-AstraZeneca |
Adenovirus |
Phases 2 and 3 combined phases |
Approved for use by WHO |
Yes |
| Approved in 93 countries | ||||
| Johnson & Johnson |
Non-replicating viral vector |
Completed Phase 3 |
Approved for use by WHO |
Yes |
| Approved in 41 countries | ||||
| Sputnik V |
Recombinant adenovirus |
Completed Phase 3 |
Approved in 65 countries |
Yes |
| CanSino |
Non-replicating viral vector |
Phase 3 |
Approved in 5 countries |
No |
| Novavax |
Protein subunit |
Phase 3 |
Not yet approved |
No |
| Sinopharm | Inactivated | Phase 3 | Approved in 40 countries | No |
WHO – World Health Organization